Acclaro Medical Raises $23 Million in Series B Funding Led by Accelmed Partners to Advance Groundbreaking 2910 nm Fiber Laser Technology

Acclaro Medical Raises $23 Million in Series B Funding Led by Accelmed Partners to Advance Groundbreaking 2910 nm Fiber Laser Technology

Accelmed $20 Million Investment with 3E Bioventures Capital Funding of $3 Million to Drive Innovation, Clinical Expansion, and Global Market Growth

Acclaro Medical secures $23m in Series B funding for skin laser technologies

Acclaro Medical has completed a Series B funding round, raising $23m, to spur the growth of its flagship products, UltraClear and AuraLux,The post Acclaro Medical secures $23m in Series B funding for skin laser technologies appeared first on Medical Device Network.

Acclaro Medical Raises $23M in Series B Funding

Acclaro Medical, a Smithfield, RI-based medical technology company focused on developing solutions for patient care and medical practices, raised $23M in Series B funding. The round was led by Accelmed Partners with participation from existing investor 3E Bioventures Capital. The company intends to use the funds to accelerate the growth of its flagship products, UltraClear and AuraLux, and expedite global market […] The post Acclaro Medical Rais…

Accelus Secures New Growth Financing To Support Continued Commercial Expansion and Pipeline Innovation – Ortho Spine News

Industry Veteran Bernie Haffey Appointed Chairman of Accelus Board of Directors PALM BEACH GARDENS, Fla., May 29, 2025 -(BUSINESS WIRE)- Accelus (“The Company”), a privately held medical technology company committed to becoming the global market leader in expandable spinal implant technologies, today announced the closing of a new equity financing round led by Concord Health Partners, a healthcare-focused investment firm. The capital will support